Amneal Pharmaceuticals, Inc. AMRX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s operating cash flow?
- Amneal Pharmaceuticals, Inc. (AMRX) reported operating cash flow of -$26.74M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s operating cash flow decreased by 461.0% year-over-year, from $7.41M to -$26.74M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s operating cash flow?
- Over 2 years (2023 to 2025), Amneal Pharmaceuticals, Inc.'s operating cash flow has grown at a -2.4% compound annual growth rate (CAGR), from $356.92M to $339.99M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.